Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Heshmatolah Majlessi

Neurological Surgery Clinton, MD Medical Doctor

NPI 1649261306 CMS profile 210638

7503 Surratts Rd, Ste 206, Clinton, MD 20735

Open in the dashboard

General payments

$4,723

234 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Heshmatolah Majlessi of Clinton, MD is reported in the CMS Open Payments database as having received $4,723 across 234 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 57th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $29 2
2022 General $199 7
2021 General $2,038 123
2020 General $452 25
2019 General $2,006 77

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Heshmatolah Majlessi
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Heshmatolah Majlessi were reported at $0. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Heshmatolah Majlessi Neurological Surgery median Middle half National median
2019 $2,006 $582 $138–$3,006 $163
2020 $452 $294 $76–$2,174 $114
2021 $2,038 $387 $105–$2,432 $132
2022 $199 $542 $139–$2,989 $149
2023 $29 $534 $145–$2,697 $160
2024 $0 $574 $155–$3,046 $164
2025 $0 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Novartis Pharmaceuticals Corporation $1,082 56 payments
  2. Lilly USA, LLC $434 23 payments
  3. Biogen, Inc. $420 23 payments
  4. Genzyme Corporation $353 11 payments
  5. UCB, Inc. $336 14 payments
  6. Teva Pharmaceuticals USA, Inc. $306 12 payments
  7. Biohaven Pharmaceuticals, Inc. $237 20 payments
  8. EMD Serono, Inc. $230 13 payments
  9. Neurocrine Biosciences, Inc. $226 7 payments
  10. AbbVie, Inc. $205 10 payments
  11. Other $894 45 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $4,699 232 payments
  2. Education $12 1 payment
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12 1 payment
Products named General payments · program years 2019–2023
  1. MAYZENT $501 33 payments
  2. KESIMPTA $327 29 payments
  3. EMGALITY $311 20 payments
  4. AIMOVIG $306 11 payments
  5. NURTEC ODT $237 20 payments
  6. REYVOW $218 14 payments
  7. AUSTEDO $191 6 payments
  8. UBRELVY $187 9 payments
  9. Vimpat $174 10 payments
  10. AUBAGIO $172 5 payments
  11. Other $2,329 129 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

234 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record